Literature DB >> 17712045

Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis.

Chahrazade Kantari1, Magali Pederzoli-Ribeil, Omid Amir-Moazami, Valérie Gausson-Dorey, Ivan Cruz Moura, Marie-Christine Lecomte, Marc Benhamou, Véronique Witko-Sarsat.   

Abstract

Proteinase 3 (PR3), a serine proteinase contained in neutrophil azurophilic granules, is considered a risk factor for vasculitides and rheumatoid arthritis when expressed on the outer leaflet of neutrophil plasma membrane and is the preferred target of antineutrophil cytoplasm autoantibodies (ANCA) in Wegener granulomatosis. ANCA binding to PR3 expressed at the surface of neutrophils activates them. Evidence is provided that neutrophil apoptosis induced significantly more membrane PR3 expression without degranulation (but no enhanced membrane CD35, CD66b, CD63, myeloperoxidase, or elastase expression). This observation was confirmed on cytoplasts, a model of granule-free neutrophils. We hypothesized that PR3 could interact with proteins involved in membrane flip-flop (eg, phospholipid scramblase 1 [PLSCR1]). PR3-PLSCR1 interaction in neutrophils was demonstrated by confocal microscopy and coimmunoprecipitation. In the RBL-2H3 rat mast-cell line stably transfected with PR3 or its inactive mutant (PR3S203A), PR3 externalization depended on PLSCR1, as shown by less PR3 externalization in the presence of rPLSCR1 siRNA, but independently of its serine-proteinase activity. Finally, apoptosis-externalized PR3 decreased the human macrophage-phagocytosis rate of apoptotic PR3 transfectants. Therefore, in addition to ANCA binding in vasculitis, the proinflammatory role of membrane PR3 expression may involve interference with macrophage clearance of apoptotic neutrophils.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17712045     DOI: 10.1182/blood-2007-03-080457

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  The use of small molecule high-throughput screening to identify inhibitors of the proteinase 3-NB1 interaction.

Authors:  M Choi; C Eulenberg; S Rolle; J P von Kries; F C Luft; R Kettritz
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

Review 2.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 3.  Wegener's granulomatosis: the current view.

Authors:  Frank Moosig; Peter Lamprecht; Wolfgang L Gross
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 4.  Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity.

Authors:  Jolien Suurmond; Betty Diamond
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

Review 5.  The role of neutrophil death in chronic inflammation and cancer.

Authors:  Christine Brostjan; Rudolf Oehler
Journal:  Cell Death Discov       Date:  2020-04-22

Review 6.  Changing world of neutrophils.

Authors:  Csaba I Timár; Akos M Lőrincz; Erzsébet Ligeti
Journal:  Pflugers Arch       Date:  2013-05-01       Impact factor: 3.657

Review 7.  B cell-mediated pathogenesis of ANCA-mediated vasculitis.

Authors:  J Charles Jennette; Ronald J Falk
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

8.  Catalytic activity and inhibition of wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils.

Authors:  Brice Korkmaz; Jérôme Jaillet; Marie-Lise Jourdan; Alexandre Gauthier; Francis Gauthier; Sylvie Attucci
Journal:  J Biol Chem       Date:  2009-05-15       Impact factor: 5.157

9.  Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival.

Authors:  Véronique Witko-Sarsat; Julie Mocek; Dikra Bouayad; Nicola Tamassia; Jean-Antoine Ribeil; Céline Candalh; Noélie Davezac; Nathalie Reuter; Luc Mouthon; Olivier Hermine; Magali Pederzoli-Ribeil; Marco A Cassatella
Journal:  J Exp Med       Date:  2010-10-25       Impact factor: 14.307

Review 10.  ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.

Authors:  Divi Cornec; Emilie Cornec-Le Gall; Fernando C Fervenza; Ulrich Specks
Journal:  Nat Rev Rheumatol       Date:  2016-07-28       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.